PT2838554T - Parasitas plasmodium de roedor utilizados como plataformas para uma vacina contra a malária à base de organismos inteiros - Google Patents

Parasitas plasmodium de roedor utilizados como plataformas para uma vacina contra a malária à base de organismos inteiros

Info

Publication number
PT2838554T
PT2838554T PT13726295T PT13726295T PT2838554T PT 2838554 T PT2838554 T PT 2838554T PT 13726295 T PT13726295 T PT 13726295T PT 13726295 T PT13726295 T PT 13726295T PT 2838554 T PT2838554 T PT 2838554T
Authority
PT
Portugal
Prior art keywords
platforms
whole
malaria vaccine
plasmodium parasites
rodent plasmodium
Prior art date
Application number
PT13726295T
Other languages
English (en)
Inventor
Manuel Dias Da Mota Maria
Manuel Barbeiro Mendes António
Miguel Prudêncio Pignatelli Rui
Original Assignee
Inst De Medicina Molecular
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst De Medicina Molecular filed Critical Inst De Medicina Molecular
Publication of PT2838554T publication Critical patent/PT2838554T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT13726295T 2012-04-17 2013-04-17 Parasitas plasmodium de roedor utilizados como plataformas para uma vacina contra a malária à base de organismos inteiros PT2838554T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT10626212 2012-04-17

Publications (1)

Publication Number Publication Date
PT2838554T true PT2838554T (pt) 2018-11-23

Family

ID=48539330

Family Applications (1)

Application Number Title Priority Date Filing Date
PT13726295T PT2838554T (pt) 2012-04-17 2013-04-17 Parasitas plasmodium de roedor utilizados como plataformas para uma vacina contra a malária à base de organismos inteiros

Country Status (11)

Country Link
US (1) US9655957B2 (pt)
EP (1) EP2838554B1 (pt)
JP (1) JP6096884B2 (pt)
CN (1) CN104302313B (pt)
AU (1) AU2013250814B2 (pt)
BR (1) BR112014025823A8 (pt)
HK (1) HK1206243A1 (pt)
IN (1) IN2014MN02275A (pt)
PT (1) PT2838554T (pt)
WO (1) WO2013156949A1 (pt)
ZA (1) ZA201408440B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104771752B (zh) * 2015-04-21 2018-01-05 中国人民解放军第三军医大学 疟疾红内期灭活全虫疫苗的新用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1706418B1 (en) * 2003-12-19 2018-08-22 Seattle Biomedical Research Institute Live genetically attenuated malaria vaccine
US7722860B2 (en) * 2004-12-03 2010-05-25 Seattle Biomedical Research Institute Live genetically engineered protozoan vaccine
FR2978048B1 (fr) * 2011-07-20 2014-10-10 Univ Paris Curie Composition vaccinale contre le paludisme

Also Published As

Publication number Publication date
IN2014MN02275A (pt) 2015-08-07
HK1206243A1 (en) 2016-01-08
US9655957B2 (en) 2017-05-23
WO2013156949A1 (en) 2013-10-24
BR112014025823A2 (pt) 2017-06-20
BR112014025823A8 (pt) 2017-07-25
EP2838554B1 (en) 2018-08-22
JP2015514745A (ja) 2015-05-21
EP2838554A1 (en) 2015-02-25
US20150071966A1 (en) 2015-03-12
ZA201408440B (en) 2015-12-23
JP6096884B2 (ja) 2017-03-15
AU2013250814B2 (en) 2017-03-02
AU2013250814A1 (en) 2014-12-04
CN104302313B (zh) 2018-01-26
CN104302313A (zh) 2015-01-21

Similar Documents

Publication Publication Date Title
SG11201406799XA (en) A delayed release drug formulation
HK1206972A1 (en) Microparticle vaccine against malaria
HK1199199A1 (en) Blood stage malaria vaccine
HRP20190470T1 (hr) Formulacija lijeka s odgođenim otpuštanjem
ZA201403950B (en) Vaccine for falciparum malaria
ZA201404512B (en) Malaria vaccine
HK1206243A1 (en) Rodent plasmodium parasites as platforms for a whole-organism malaria vaccine
EP2548572A4 (en) TOLEROGENES ADJUVATED AS VACCINES AGAINST MALARIA
AP2014007732A0 (en) Vaccine for falciparum malaria
GB2501244B (en) Secure platform for a ladder